BLT benitec biopharma limited

Biomics and Benitec

  1. 2,820 Posts.
    lightbulb Created with Sketch. 618
    Meet our new competitor in the race for a hep b therapeutic.

    “”The Company believes that now is the appropriate time to maximise the CoSensia opportunity in China and globally, and at the same time advance its Hepatitis B virus (HBV) therapeutic program to the clinical proof of concept stage.””

    Both companies competing for the billion dollar Hep b market and Benitec former boss Peter French now a board member with the Chinese entity.

    http://www.biomics.com/about_board.html

 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.